li zhang, doctor
Sun Yat-sen University
6
6
2
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
You Lu, MD
West China Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jun Ma, M.D.
Sun Yat-sen University
Shared therapeutic areas:
Worked with same sponsors:
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
shun lu, MD
Shanghai Chest Hospital
Shared therapeutic areas:
Ming-yuan Chen, MD, PhD
Sun Yat-sen University
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors
A Study of QL1706 in Subjects With Advanced Malignant Tumor
Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)
Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC
Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
All 6 trials loaded